ascorbic-acid and 2-4-6-tripyridyl-s-triazine

To assess whether consumption of 500 ml of blueberry juice or cranberry juice by healthy female subjects increased plasma phenolic content and antioxidant capacity.. Latin square arrangement to eliminate ordering effects. After an overnight fast, nine volunteers consumed 500 ml of blueberry juice, cranberry juice or a sucrose solution (control); each volunteer participated on three occasions one week apart, consuming one of the beverages each time. Blood samples were obtained by venipuncture at intervals up to four hours after consumption of the juices. Urine samples were also obtained four hours after consuming the juice.. Consumption of cranberry juice resulted in a significant increase in the ability of plasma to reduce potassium nitrosodisulphonate and Fe(III)-2,4, 6-Tri(2-pyridyl)-s-triazine, these measures of antioxidant capacity attaining a maximum after 60-120 min. This corresponded to a 30% increase in vitamin C and a small but significant increase in total phenols in plasma. Consumption of blueberry juice had no such effects.. The increase in plasma antioxidant capacity following consumption of cranberry juice could mainly be accounted for by an increase in vitamin C rather than phenolics. This also accounted for the lack of an effect of the phenolic-rich but vitamin C-low blueberry juice.. Funded by the Scottish Executive Rural Affairs Department and the Danish Government.

Topics: Adult; Antioxidants; Ascorbic Acid; Beverages; Chelating Agents; Female; Ferric Compounds; Fruit; Humans; Kinetics; Nitroso Compounds; Oxidation-Reduction; Phenols; Triazines

Ascorbic acid (AA) is a water-soluble vitamin which shows no fluorescence. However, in reaction with iron(III), AA is oxidised to dehydroascorbic acid and iron(III) is reduced to iron(II) which forms a complex with 2,4,6-tripyridyl-S-triazine (TPTZ) in buffered medium. The relative fluorescence intensity of the resulting Fe(TPTZ)₂(2+) complex can be measured at excitation and emission wavelengths of 393 and 790 nm, respectively. Based on this data, a new indirect spectrofluorimetric method for the determination of AA in pharmaceutical samples was proposed. Influence of the reaction conditions, such as acidity of acetic buffer, concentration of TPTZ and iron(III), reaction time and instrumental parameters were investigated in detail. The linear range was from 5.4 × 10(-4) to 5.4 × 10(-6) mol·L(-1) (R = 0.9971). The LOD was 7.7 × 10(-7) mol·L(-1) and LOQ was 2.3 × 10(-4) mol·L(-1). Fourteen pharmaceutical samples containing various amounts of AA were analysed. Influences of potential interfering substances were also examined. Analysis of commercial pharmaceutical formulations showed good correlation with the nominal values given by the manufacturers and with the results obtained by a titration method. The proposed method can be applied in routine quality control in the pharmaceutical industry due to its sensitivity, simplicity, selectivity and low cost.

Topics: Ascorbic Acid; Ferric Compounds; Hydrogen-Ion Concentration; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Triazines

A flow-injection indirect spectrophotometric method for the determination of ascorbic acid (AA) in pharmaceutical preparations is proposed. The method is based on the reduction of iron(III) to iron(II) by the AA, and by the subsequent reaction of the produced iron(II) with 2,4,6-tripyridyl-s-triazine (TPTZ) in buffered medium (pH=3.6) to form a coloured complex (λ(max)=593nm). The three-line manifold with one reaction coil was used. The linear range of the method is from 0.08 to 10μM of ascorbic acid, with the detection limit 24nM of AA. The proposed method is simple, rapid (sampling rate of 180 samples per hour), sensitive and reproducible (RSD 0.8%, n=100). The proposed method is very selective, because only the reducing substances with standard (formal) potentials lower than 0.6V would have the thermodynamic predisposition to interfere in the proposed method. Tested reducing substances (thiol compounds) did not give serious errors when present at the same concentrations as the ascorbic acid. The proposed method can be applied for the determination of AA in pharmaceutical preparations, down to picomolar quantity.

Topics: Ascorbic Acid; Calibration; Color; Drug Compounding; Flow Injection Analysis; Reproducibility of Results; Spectrophotometry; Triazines

Topics: Ascorbate Oxidase; Ascorbic Acid; Ascorbic Acid Deficiency; Blood Chemical Analysis; Chlorides; Colorimetry; Ferric Compounds; Humans; Hydrogen-Ion Concentration; Oxidation-Reduction; Time Factors; Triazines

We describe a specific enzymatic spectrophotometric method for ascorbic acid in serum or plasma. Samples are analyzed indirectly by measuring the absorbance at 593 nm of a reaction product, a complex of ferrous ion and 2,4,6-tris(2-pyridyl)-s-triazine (Fe2+-TPTZ). This product is formed by reduction of the corresponding ferric ion complex (Fe3+-TPTZ), which is nonspecifically reduced by various biological reducing agents under acidic conditions. Ascorbic acid is specifically quantified by pretreating one of a pair of replicate samples with ascorbate oxidase (EC 1.10.3.3), to oxidize the ascorbic acid, then reacting both samples with Fe3+-TPTZ and measuring the difference between the absorbances at 593 nm of the treated and untreated samples. This difference is linearly related to ascorbic acid concentrations from 10 to 100 mg/L. Ten repeat determinations of a serum pool with added ascorbic acid yielded a CV of 2.8% and a mean of 47.2 mg/L. The correlation (r) between the proposed method and the dinitrophenylhydrazine method was 0.93 for 32 samples analyzed by both methods. The present method is specific for ascorbic acid and requires no deproteinization.

Topics: Ascorbate Oxidase; Ascorbic Acid; Ferrous Compounds; Humans; Indicators and Reagents; Oxidoreductases; Spectrophotometry; Time Factors; Triazines

A method is described for the assay of ascorbic acid in either serum or heparinized plasma. 1. The assay is based on the reduction of ferric chloride by ascorbic acid with the resulting ferrous ion quantitated by the addition of 2,4,6-tripyridyl-s-triazine to form a purple colour with a maximum absorbance at 595 nm. 2. Uric acid interference has been eliminated by the use of a high molarity acetate buffer and by optimising the amount of TPTZ and ferric chloride used. 3. Protein was found to cause rapid fading of the final colour; it was therefore necessary to remove the protein, by addition of 10% trichloroacetic acid, from the specimen prior to the final assay. This had the added advantage of assisting to stabilize the ascorbic acid prior to final assay. 4. All reagents used are easily obtained and no special equipment is required.

Topics: Ascorbic Acid; Blood Proteins; Buffers; Ferric Compounds; Hydrogen-Ion Concentration; Methods; Osmolar Concentration; Pyridines; Spectrophotometry; Triazines; Uric Acid